These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15970778)

  • 1. Estimating patient time costs associated with colorectal cancer care.
    Yabroff KR; Warren JL; Knopf K; Davis WW; Brown ML
    Med Care; 2005 Jul; 43(7):640-8. PubMed ID: 15970778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient time costs associated with cancer care.
    Yabroff KR; Davis WW; Lamont EB; Fahey A; Topor M; Brown ML; Warren JL
    J Natl Cancer Inst; 2007 Jan; 99(1):14-23. PubMed ID: 17202109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
    Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer.
    Brown ML; Riley GF; Potosky AL; Etzioni RD
    Med Care; 1999 Dec; 37(12):1249-59. PubMed ID: 10599606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of care for elderly cancer patients in the United States.
    Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
    J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating health care costs related to cancer treatment from SEER-Medicare data.
    Brown ML; Riley GF; Schussler N; Etzioni R
    Med Care; 2002 Aug; 40(8 Suppl):IV-104-17. PubMed ID: 12187175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source?
    Yabroff KR; Warren JL; Banthin J; Schrag D; Mariotto A; Lawrence W; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S64-9. PubMed ID: 19536016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-Attributable Medical Costs for Colorectal Cancer Patients by Phases of Care: What Is the Effect of a Prior Cancer History?
    Mariotto AB; Warren JL; Zeruto C; Coughlan D; Barrett MJ; Zhao L; Yabroff KR
    J Natl Cancer Inst Monogr; 2020 May; 2020(55):22-30. PubMed ID: 32412066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of trends in the cost of initial cancer treatment.
    Warren JL; Yabroff KR; Meekins A; Topor M; Lamont EB; Brown ML
    J Natl Cancer Inst; 2008 Jun; 100(12):888-97. PubMed ID: 18544740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study.
    Etzioni R; Ramsey SD; Berry K; Brown M
    Health Econ; 2001 Apr; 10(3):245-56. PubMed ID: 11288190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical Care Costs Associated With Cancer in Integrated Delivery Systems.
    Banegas MP; Yabroff KR; O'Keeffe-Rosetti MC; Ritzwoller DP; Fishman PA; Salloum RG; Lafata JE; Hornbrook MC
    J Natl Compr Canc Netw; 2018 Apr; 16(4):402-410. PubMed ID: 29632060
    [No Abstract]   [Full Text] [Related]  

  • 13. Projections of the cost of cancer care in the United States: 2010-2020.
    Mariotto AB; Yabroff KR; Shao Y; Feuer EJ; Brown ML
    J Natl Cancer Inst; 2011 Jan; 103(2):117-28. PubMed ID: 21228314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Projections of the costs associated with colorectal cancer care in the United States, 2000-2020.
    Yabroff KR; Mariotto AB; Feuer E; Brown ML
    Health Econ; 2008 Aug; 17(8):947-59. PubMed ID: 17910108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences among the elderly in the treatment costs of colorectal cancer: how important is race?
    Wright GE; Barlow WE; Green P; Baldwin LM; Taplin SH
    Med Care; 2007 May; 45(5):420-30. PubMed ID: 17446828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data.
    Lang K; Lines LM; Lee DW; Korn JR; Earle CC; Menzin J
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):198-204. PubMed ID: 18849013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer.
    Ramsey SD; Berry K; Etzioni R
    Am J Gastroenterol; 2002 Feb; 97(2):440-5. PubMed ID: 11866285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time costs associated with informal care for colorectal cancer: an investigation of the impact of alternative valuation methods.
    Hanly P; Céilleachair AÓ; Skally M; O'Leary E; Staines A; Kapur K; Fitzpatrick P; Sharp L
    Appl Health Econ Health Policy; 2013 Jun; 11(3):193-203. PubMed ID: 23549793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring costs: administrative claims data, clinical trials, and beyond.
    Etzioni R; Riley GF; Ramsey SD; Brown M
    Med Care; 2002 Jun; 40(6 Suppl):III63-72. PubMed ID: 12064760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter?
    Chen AB; Li L; Cronin AM; Brooks GA; Kavanagh BD; Schrag D
    Health Serv Res; 2018 Aug; 53 Suppl 1(Suppl Suppl 1):3227-3244. PubMed ID: 28858372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.